← Eichor
Condition: Conditioning Synced from ClinicalTrials.gov · July 30, 2026

Recruiting studies: Conditioning

Studies currently listed as recruiting on the public registry for this search term. Each page explains the study in plain language, with locations and the study team's contact details. Clinicians: generate a printable list for your patient →

Ruxolitinib-Enhanced Haplo HCT for Children and Young Adults With Sickle Cell Disease
Phase 1/Phase 2 · 4 location(s) · Arkansas Children's Hospital Research Institute · NCT07252050Pralatrexate With Bendamustine and Total-Body Irradiation Followed by Donor Stem Cell Transplant for the Treatment of Re
Phase 1/Phase 2 · 1 location(s) · Fred Hutchinson Cancer Center · NCT07225985Hemodynamic Variations During Remote Ischemic Conditioning in Critical Ill Patients
NA · 1 location(s) · Lithuanian University of Health Sciences · NCT06536231Safety and Efficacy of Remote Ischemic Conditioning for Patients Taking Off-pump Coronary Artery Bypass Grafting
NA · 1 location(s) · First Affiliated Hospital Xi'an Jiaotong University · NCT06141525REmote COnditioning in Out-of-Hospital Cardiac Arrest
NA · 14 location(s) · Hospices Civils de Lyon · NCT06306625Using Exercise to Enhance Fear Extinction Learning
NA · 1 location(s) · Josh Cisler · NCT07548125Evaluating the Efficacy of a Mobile Application in Postoperative Rehabilitation
NA · 1 location(s) · Yale University · NCT06407427A Single-arm, Prospective Study of a Clad-LABU Conditioning Regimen in HSCT for R/R MDS/AML in Elderly Patients
NA · 1 location(s) · The First Affiliated Hospital of Soochow University · NCT07500753VA Conditioning Regimen Allo-HSCT for Elderly Higher-risk MDS
Phase 1/Phase 2 · 1 location(s) · Navy General Hospital, Beijing · NCT06471946Sirolimus Pre-conditioning on T Cell Activity and T-cell Engaging Bispecific Antibody Efficacy in Multiple Myeloma
Phase 1 · 1 location(s) · Christopher Strouse · NCT07581704Thal-Fabs: Reduced Toxicity Conditioning for High Risk Thalassemia
Phase 1/Phase 2 · 1 location(s) · The Hospital for Sick Children · NCT05426252REmote iSchemic condItioning in Lymphoma PatIents REceiving ANthraCyclinEs
NA · 24 location(s) · Fundación Centro Nacional de Investigaciones Cardiovasculare · NCT05223413Post-Transplant Cyclophosphamide in Patients Aged >/= 65 Years Undergoing Haploidentical Transplant
Phase 1 · 1 location(s) · Ronald Paquette · NCT05849207Study on the Efficacy and Safety of the TmBU Conditioning Regimen in High-risk or Relapsed/Refractory Acute Leukemia
Phase 2 · 1 location(s) · The First Affiliated Hospital of Soochow University · NCT06816134Remote Ischemic Conditioning for Non-Proliferative Diabetic Retinopathy
NA · 2 location(s) · Xuxiang Zhang, MD · NCT06713720Stimulation-Induced Changes in Fronto-Limbic Network
NA · 1 location(s) · University of Alabama at Birmingham · NCT05854160Study of Combined Kidney and Blood Stem Cell Transplant From a Brother or Sister Donor
Phase 1/Phase 2 · 1 location(s) · Jeffrey Veale, MD · NCT03707262Conditioning Electrical Stimulation to Improve Outcomes in Cubital Tunnel Syndrome
NA · 1 location(s) · University of Alberta · NCT05395715Is Conditioned Pain Modulation Predictive of Clinical Improvement in Patients With Chronic Low Back Pain?
NA · 1 location(s) · Brooke Army Medical Center · NCT06544525MT2023-20: Hematopoietic Cell Transplant With Reduced Intensity Conditioning and Post-transplant Cyclophosphamide for Se
Phase 2 · 1 location(s) · Masonic Cancer Center, University of Minnesota · NCT06412497Assessment of Pressure Pain Threshold (PPT) and Conditioned Pain Modulation (CPM) After Effect in Patients With and With
NA · 1 location(s) · The Hashemite University · NCT07178288A Novel Conditioning Regimen for Haplo-HSCT in Older Patients With SAA
Phase N/A · 1 location(s) · Peking University People's Hospital · NCT07586735AHSCT With Fludarabine and Cyclophosphamide Based Conditioning Regimes in Patients With Multiple Sclerosis
Phase 1 · 1 location(s) · St. Petersburg State Pavlov Medical University · NCT05832515Allogeneic Hematopoietic Stem Cell Transplantation for Chronic Granulomatous Disease (CGD) With an Alemtuzumab, Busulfan
Phase 1/Phase 2 · 1 location(s) · National Institute of Allergy and Infectious Diseases (NIAID · NCT05463133Thiotepa-Containing Conditioning Regimen for Allogeneic HSCT in Chronic Myelomonocytic Leukemia
NA · 1 location(s) · Peking University People's Hospital · NCT07588594Amimestrocel Injection for Preventing Severe Oral Mucositis in HSCT Patients
Phase 2 · 1 location(s) · The First Affiliated Hospital of Soochow University · NCT07400328Campath/Fludarabine/Melphalan Transplant Conditioning for Non-Malignant Diseases
Phase 1/Phase 2 · 28 location(s) · Washington University School of Medicine · NCT00920972Remote Ischemic Preconditioning for Aute Type A Aortic Dissection Surgery
NA · 3 location(s) · Fujian Medical University · NCT07383909A Prospective, Open-label, Randomized Controlled, Multicenter Clinical Study of MSD-HSCT Using a TBI or TMLI Conditionin
Phase 2 · 1 location(s) · The First Affiliated Hospital of Zhengzhou University · NCT06564493Delayed Immunological Tolerance in Patients With Well-functioning Pre-existing HLA-matched Kidney Transplants
Phase 1 · 1 location(s) · University of California, Los Angeles · NCT05525507
Look up another condition
Patient organization or foundation? You can brand this page for your community — your logo, your resources, same honest registry data, kept current daily. Ask about branding →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.